Fig. 2From: Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning studyMean liver dose (MLD, a) and proportion of circulating lymphocytes receiving ≥0.5Gy (CL0.5) by treatment modality as mean values with SD for all intrahepatic locations (b)Back to article page